Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome.
Protic D, Breeze E, Mendoza G, Zafarullah M, Abbeduto L, Hagerman R, Coffey C, Cudkowicz M, Durbin-Johnson B, Ashwood P, Berry-Kravis E, Erickson CA, Filipink R, Gropman A, Lehwald L, Maxwell-Horn A, Morris S, Bennett AP, Prock L, Talboy A, Tartaglia N, Veenstra-VanderWeele J, Tassone F. Protic D, et al. Among authors: coffey c. SAGE Open Med. 2024 Sep 29;12:20503121241282401. doi: 10.1177/20503121241282401. eCollection 2024. SAGE Open Med. 2024. PMID: 39483619 Free PMC article.
Opportunities for improving therapy development in ALS.
Bruijn L, Cudkowicz M; ALS Clinical Trials Working Group. Bruijn L, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):169-73. doi: 10.3109/21678421.2013.872662. Epub 2014 Jan 29. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24472060
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia.
Weintraub D, Nair AR, Kurth R, Brumm MC, York MK, Dobkin R, Marek K, Tanner C, Simuni T, Siderowf A, Galasko D, Chahine LM, Coffey C, Merchant K, Poston KL, Foroud T, Mollenhauer B, Brown EG, Kieburtz K, Frasier M, Sherer T, Chowdhury S, Alcalay RN, Videnovic A; Parkinson’s Progression Markers Initiative. Weintraub D, et al. Among authors: coffey c. medRxiv [Preprint]. 2024 Dec 13:2024.12.12.24318917. doi: 10.1101/2024.12.12.24318917. medRxiv. 2024. PMID: 39711699 Free PMC article. Preprint.
Virtual Home Care for Patients With Acute Illness.
Banerjee J, Lynch C, Gordon H, Coffey CE Jr, Canamar CP, Tangpraphaphorn S, Gonzalez K, Mahajan N, Shoenberger J, Menchine M, Oh A, Johnson E, Grassini M, Baden R, Holtom P, Hutcheon D, Wiley BM, Davar K, Mallet-Smith S, Sanfratello M, Gallardo B, Song M, Swain N, Solis ML, Silva J, Pablico C, Aceves E, Bonilla E, Legaspi RA, Guevara DM, Lee K, Martinez C, Banh M, Russell D, Cervantes L, Cervantes J, Gonzalez C, Sheth P, Dowlatshahi S, Rosenberg A, Patel P, Lee WA, Khan T, Tan TW, Fong M, Gordon SS, Clark B, Pena V, Dohi S, Bannister B, Villalta R, Induru P, Vuong P, Lwe D, Stoffel K, Oh S, Voyageur C, Cool A, Lee Y, Lenh S, Luong J, Hanna G, Doctor JN, Munoz B, Castro C, Solis E, Blake N, Sakzalyan R, Rodriguez CJ, Ghaly C, Orozco J, Yee HF Jr, Spellberg B. Banerjee J, et al. Among authors: coffey ce jr. JAMA Netw Open. 2024 Nov 4;7(11):e2447352. doi: 10.1001/jamanetworkopen.2024.47352. JAMA Netw Open. 2024. PMID: 39589741 Free PMC article.
Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's Disease.
Gonzalez-Latapi P, Gochanour C, Cho H, Ho Choi S, Caspell-Garcia C, Coffey C, Brumm M, Lafontant DE, Xiao Y, Tanner C, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Siderowf A, Marek K, Simuni T. Gonzalez-Latapi P, et al. Among authors: coffey c. medRxiv [Preprint]. 2024 Oct 10:2024.10.09.24315191. doi: 10.1101/2024.10.09.24315191. medRxiv. 2024. PMID: 39417131 Free PMC article. Preprint.
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz K, Merchant K, Mollenhauer B, Montine TJ, Nudelman K, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tolosa E, Siderowf A, Dunn B, Simuni T, Marek K; Parkinson’s Progression Markers Initiative. Dam T, et al. Among authors: coffey c. NPJ Parkinsons Dis. 2024 Sep 27;10(1):178. doi: 10.1038/s41531-024-00789-w. NPJ Parkinsons Dis. 2024. PMID: 39333167 Free PMC article.
Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts.
Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz K, Merchant K, Mollenhauer B, Montine TJ, Nudelman K, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tolosa E, Siderowf A, Dunn B, Simuni T, Marek K; Parkinson’s Progression Markers Initiative. Dam T, et al. Among authors: coffey c. medRxiv [Preprint]. 2024 Sep 10:2024.02.14.24302818. doi: 10.1101/2024.02.14.24302818. medRxiv. 2024. Update in: NPJ Parkinsons Dis. 2024 Sep 27;10(1):178. doi: 10.1038/s41531-024-00789-w PMID: 39314957 Free PMC article. Updated. Preprint.
716 results